- Home
- WINT vs BACK Comparison
WINT vs BACK Comparison
Compare WINT & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- BACK
- Stock Information
- Founded
- WINT 1992
- BACK 2000
- Country
- WINT United States
- BACK United States
- Employees
- WINT N/A
- BACK N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- BACK Medical Specialities
- Sector
- WINT Health Care
- BACK Health Care
- Exchange
- WINT Nasdaq
- BACK Nasdaq
- Market Cap
- WINT 2.0M
- BACK 1.6M
- IPO Year
- WINT 1995
- BACK 2019
- Fundamental
- Price
- WINT $0.12
- BACK $0.65
- Analyst Decision
- WINT Hold
- BACK
- Analyst Count
- WINT 1
- BACK 0
- Target Price
- WINT $7.00
- BACK N/A
- AVG Volume (30 Days)
- WINT 7.3M
- BACK 3.7M
- Earning Date
- WINT 11-27-2024
- BACK 01-17-2025
- Dividend Yield
- WINT N/A
- BACK N/A
- EPS Growth
- WINT N/A
- BACK N/A
- EPS
- WINT N/A
- BACK N/A
- Revenue
- WINT N/A
- BACK $72,050.00
- Revenue This Year
- WINT N/A
- BACK N/A
- Revenue Next Year
- WINT N/A
- BACK N/A
- P/E Ratio
- WINT N/A
- BACK N/A
- Revenue Growth
- WINT N/A
- BACK N/A
- 52 Week Low
- WINT $0.11
- BACK $0.47
- 52 Week High
- WINT $14.75
- BACK $7.75
- Technical
- Relative Strength Index (RSI)
- WINT 15.60
- BACK 38.65
- Support Level
- WINT $0.21
- BACK $0.50
- Resistance Level
- WINT $0.33
- BACK $0.86
- Average True Range (ATR)
- WINT 0.03
- BACK 0.20
- MACD
- WINT 0.00
- BACK -0.05
- Stochastic Oscillator
- WINT 2.15
- BACK 19.05
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.